Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA516360
Max Phase: Preclinical
Molecular Formula: C22H31N5O3
Molecular Weight: 413.52
Molecule Type: Small molecule
Associated Items:
ID: ALA516360
Max Phase: Preclinical
Molecular Formula: C22H31N5O3
Molecular Weight: 413.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc2c(c1)/C(=N/N1CC(=O)N(CCCCN3CCN(C)CC3)C1=O)CCO2
Standard InChI: InChI=1S/C22H31N5O3/c1-17-5-6-20-18(15-17)19(7-14-30-20)23-27-16-21(28)26(22(27)29)9-4-3-8-25-12-10-24(2)11-13-25/h5-6,15H,3-4,7-14,16H2,1-2H3/b23-19+
Standard InChI Key: PDIVTNPHINYKJK-FCDQGJHFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 413.52 | Molecular Weight (Monoisotopic): 413.2427 | AlogP: 1.77 | #Rotatable Bonds: 6 |
Polar Surface Area: 68.69 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.95 | CX Basic pKa: 8.30 | CX LogP: 1.50 | CX LogD: 0.55 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.53 | Np Likeness Score: -0.98 |
1. Du L, Li M, Yang Q, Tang Y, You Q, Xia L.. (2009) Molecular hybridization, synthesis, and biological evaluation of novel chroman I(Kr) and I(Ks) dual blockers., 19 (5): [PMID:19185489] [10.1016/j.bmcl.2009.01.022] |
Source(1):